Director, Division of Experimental Therapeutics, Director, Columbia Conte Center for Schizophrenia Research, Professor of Psychiatry and Neuroscience, Columbia University College of PhysicianBiography
Daniel C Javitt, MD, PhD, is Professor of Psychiatry and Neuroscience at Columbia University College of Physicians and Surgeons, where he directs the Division of Experimental Therapeutics as well as the Columbia Conte Center for Schizophrenia Research in New York City. Additionally, Dr Javitt serves as Director of Schizophrenia Research at Nathan Kline Institute for Psychiatric Research, a New York State Office of Mental Health-supported research facility. He received his MD and PhD degrees from Albert Einstein College of Medicine. His research focuses on mechanisms underlying negative symptoms and cognitive deficits in schizophrenia and other serious mental disorders, with particular emphasis on NMDA receptors and neurophysiological assessment, and on new treatment development using both pharmacological and brain stimulation approaches. Dr Javitt has published over 250 articles on issues related to normal brain function, NMDA receptors and schizophrenia. He has received awards for his research from numerous organizations, including the Penwalt Resident Research Award from the American Psychiatric Association; The Kempf Fund Award for Research Development in Psychobiological Psychiatry from the American Psychiatric Association; the A.E. Bennett Basic Science Award from the Society for Biological Psychiatry; the Joel Elkes Research Award from the American College of Neuropsychopharmacology; and a MERIT award from the National Institutes of Mental Health. Dr Javitt serves on the editorial board of several prestigious journals including Schizophrenia Bulletin, Schizophrenia Research, and American Journal of Psychiatry. He is a Fellow of the American College of Neuropsychopharmacology and an advisory board member for the Brain and Behavior Research Foundation.